By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today announced that it has acquired a non-exclusive license to Innogenetics' hepatitis C virus genotyping patent estate in the US.

The deal includes an option to extend the license globally. Other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.